Table 3.
Beta (95% CI) | Standardized beta | P | |
---|---|---|---|
All patients, *N = 179† | |||
Hemoglobin, g/L | −3.1 (−3.6-−0.26) | −0.69 | <.001 |
Hemoglobin F, % | 0.02 (0.01-0.03) | 0.27 | <.001 |
Patients on hydroxyurea, n = 72‡ | |||
Hemoglobin, g/L | −2.7 (−3.8-−1.7) | −0.58 | <.001 |
Hemoglobin F, % | 0. 03 (0.01-0.05) | 0.32 | .005 |
Patients not on hydroxyurea, n = 107§ | |||
Hemoglobin, g/L | −3.3 (−3.9-−2.8) | −0.80 | <.001 |
Hemoglobin F, % | 0.01 (0-0.02) | 0.12 | .09 |
Includes patients for whom hemoglobin F and erythropoietin results were available. Variables entered into models were hemoglobin, hemolytic component, hemoglobin oxygen saturation, and hemoglobin F (%).
R-square = 0.51. If hemoglobin F category of 8% or higher versus lower than 8% is used in the model, P value for hemoglobin F = .001.
R-square = 0.34. If hemoglobin F category of 8% or higher versus lower than 8% is used in the model, P value for hemoglobin F = .015.
R-square = 0.61. If hemoglobin F category of 8% or higher versus lower than 8% is used in the model, P value for hemoglobin F = .3.